{
  "meta": {
    "title": "Disorders_Of_Rbc_And_Platelets",
    "url": "https://brainandscalpel.vercel.app/disorders-of-rbc-and-platelets-572f13c0.html",
    "scrapedAt": "2025-11-30T11:19:25.329Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamic acid to leucine</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Valine to leucine</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamic acid to valine</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Valine to glutamic acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What type of amino acid change is seen in sickle cell anaemia?</span></p>",
      "unique_key": "DT1230539",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230539,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li><strong>Sickle cell hemoglobinopathy</strong> arises from a <strong>point mutation</strong> in the <strong>beta-globin gene</strong> (chromosome 11), leading to the replacement of <strong>glutamic acid (hydrophilic)</strong> with <strong>valine (hydrophobic)</strong> at the <strong>sixth position</strong> of the <strong>beta-globin chain</strong>. This <strong>change causes HbS (sickle haemoglobin)</strong>.\n<ul>\n<li>The replacement of <strong>glutamic acid</strong> with <strong>valine</strong> makes the haemoglobin molecule <strong>hydrophobic</strong> at the position of mutation.</li>\n<li>The hydrophobic <strong>valine</strong> promotes <strong>polymerisation</strong> of the haemoglobin under <strong>low oxygen conditions</strong>.</li>\n<li>This <strong>polymerisation leads to the formation of long, rigid fibres</strong>, causing <strong>sickling</strong> of red blood cells (RBCs).</li>\n<li>The sickled RBCs <strong>lose their flexibility</strong> and become <strong>trapped in small vessels</strong>, causing <strong>blockages</strong> and leading to complications like <strong>pain crises</strong>, <strong>organ damage</strong>, and <strong>anaemia</strong>.</li>\n</ul>\n</li>\n<li><strong>Molecular Mechanism:<br /> </strong>\n<ul>\n<li>In deoxygenated conditions, the <strong>hydrophobic valine</strong> in HbS interacts with <strong>other HbS molecules,</strong> forming <strong>fibres</strong>.</li>\n<li>This leads to a <strong>significant decrease in the solubility of HbS</strong> compared to normal haemoglobin (HbA), which is soluble and does not polymerise.</li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024100179e50a03-187a-4257-b2cc-0e424ee5a87a.png\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20241001c2e6fb1b-6c1e-46c0-b1af-9838f01b1e24.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Glutamic acid to leucine (Option A):</strong> The mutation in sickle cell is from <strong>glutamic acid to valine</strong>, not leucine.</p>\n<p><strong>Valine to leucine (Option B):</strong> This mutation does not affect haemoglobin in sickle cell anaemia; it would not cause polymerisation.</p>\n<p><strong>Valine to glutamic acid (Option D):</strong> This mutation would result in <strong>normal haemoglobin (HbA)</strong>, which is soluble and does not polymerise.</p>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia trait</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia major</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell anemia</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteopetrosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following X-ray skull appearance is most commonly seen in which condition?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024032056ddc33a-4ad0-4569-b093-3c940d77d6ab.jpg\"></span></p>",
      "unique_key": "DT1230541",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230541,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>The \"<strong>hair on end\" appearance</strong> on a skull X-ray is characteristic of <strong>thalassemia major</strong>.</li>\n<li>This radiologic finding occurs due to the <strong>widening of the diploic spaces</strong> in the skull, which is a result of <strong>marrow hyperplasia</strong> due to <strong>severe anaemia</strong>.</li>\n<li>In <strong>thalassemia major</strong>, there is <strong>ineffective erythropoiesis</strong> and <strong>compensatory extramedullary hematopoiesis</strong> (i.e., the bone marrow expands and causes the skull to show this characteristic appearance).</li>\n<li>The excessive bone marrow expansion results in trabecular bone formation, which gives rise to the \"hair on end\" pattern.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Thalassemia trait (Option A):</strong> This condition is <strong>asymptomatic</strong> and <strong>does not show</strong> the \"hair on end\" skull appearance.</p>\n<p><strong>Sickle cell anaemia (Option C):</strong> This condition may cause <strong>bone infarctions</strong> but typically does not produce the \"hair on end\" appearance on skull X-rays.</p>\n<p><strong>Osteopetrosis (Option D):</strong> This condition results in <strong>increased bone density</strong> and <strong>bone sclerosis</strong> but does not show the \"hair on end\" skull appearance.</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\"><10.5 g/dl</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\"><11 g/dl</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\"><11.5 g/dl</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\"><12 g/dl</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old girl comes to you for evaluation due to easy fatigability noticed by the parents. Her hemogram is done to look for the Hb level and diagnose anaemia. What shall be the cut-off of Hb for this child, according to WHO guidelines?</span></p>",
      "unique_key": "DT1230543",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230543,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>According to<strong> the WHO classification, anaemia in children aged 5-11 years is defined as haemoglobin &lt;11.5 g/dL.</strong></li>\n<li>This Hb threshold is used globally for diagnosing anaemia in pediatric patients in this age group, which includes the 6-year-old child in this scenario. These cut-offs are critical in identifying and managing childhood anaemia, especially in resource-limited settings</li>\n</ul>\n<p><strong>WHO Cut-offs for </strong><strong>anaemia are as follows</strong></p>\n<ul>\n<li><strong>6 months - 5 years: </strong>Hb<strong>&lt; 11gm/</strong>dl.</li>\n<li><strong>5 years - 11 years</strong>: Hb <strong>&lt; 11.5g</strong>/dl</li>\n<li><strong>12-13 years:</strong>Hb <strong>&lt;12 g</strong>/dl</li>\n<li><strong>Adult male:</strong>Hb <strong>&lt; 13g</strong>/dl</li>\n<li><strong>Adult non-pregnant female</strong>: Hb <strong>&lt; 12g</strong>/dl</li>\n</ul>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypofibrinogenemia</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor VIII deficiency</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor IX deficiency</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">vWF deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cryoprecipitate will control bleeding due to deficiency of all of the following except?</span></p>",
      "unique_key": "DT1230544",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230544,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Cryoprecipitate </strong>contains<strong> fibrinogen, factor VIII, factor XIII, von Willebrand factor (vWF), </strong>and<strong> fibronectin, </strong>but not<strong> factor IX.</strong></li>\n<li>Therefore, it is <strong>not effective</strong> in treating <strong>Factor IX deficiency</strong> (Haemophilia B). In such cases, <strong>fresh frozen plasma (FFP)</strong> or <strong>specific factor IX concentrates</strong> are used.</li>\n</ul>\n<p>Cryoprecipitate is particularly useful in the following conditions:</p>\n<ul>\n<li><strong>Hypofibrinogenemia</strong> (due to DIC or liver failure)</li>\n<li><strong>von Willebrand disease</strong> (especially types 1 and 2 if specific concentrates are unavailable)</li>\n<li><strong>Haemophilia A (Factor VIII deficiency)</strong> in emergencies if recombinant factor VIII is unavailable</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Hypofibrinogenemia (Option A):</strong> Cryoprecipitate is the treatment of choice because it is rich in fibrinogen.</p>\n<p><strong>Factor VIII deficiency (Option B):</strong> Cryoprecipitate contains factor VIII and can be used in emergencies.</p>\n<p><strong>vWF deficiency (Option D):</strong> Cryoprecipitate is a source of von Willebrand factor and may be used when specific vWF concentrates are unavailable.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemarthroses commonly occur in this disorder</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Spontaneous recovery within several weeks is expected</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet transfusion should be urgently performed</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Prothrombin time and activated partial thromboplastin time are prolonged</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-year-old girl is brought to the office with a few petechiae and bruising on the face, chest, back, and lower extremities, which her mother noticed early this morning. The mother states that her daughter has been healthy except for a viral upper respiratory illness 2 weeks ago. Laboratory assessment reveals a platelet count of 25,000/microlitre without any splenomegaly, PT and aPTT normal. Which of the following statements regarding the likely diagnosis is correct?</span></p>",
      "unique_key": "DT1230545",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230545,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>This presentation is classic for <strong>acute-onset Immune Thrombocytopenic Purpura (ITP)</strong>.</li>\n<li>Most cases of ITP in children resolve spontaneously within <strong>1-2 weeks to a few months</strong>, particularly when bleeding is not severe. Observation is sufficient for children who are hemodynamically stable and have <strong>no mucosal or life-threatening bleeding</strong>.</li>\n</ul>\n<p>Key clinical pointers:</p>\n<ul>\n<li><strong>Recent viral illness</strong> (2 weeks ago)</li>\n<li><strong>Sudden onset of petechiae and bruising</strong></li>\n<li><strong>Severe thrombocytopenia</strong> (platelet count &lt;30,000/&mu;L)</li>\n<li><strong>No splenomegaly</strong></li>\n<li><strong>Normal coagulation profile</strong></li>\n</ul>\n<p>Management of ITP in children</p>\n<ul>\n<li><strong>Observation</strong> is first-line in children with mild bleeding and platelet count &gt;20000-30,000/&mu;L.</li>\n<li><strong>First-line pharmacologic treatments</strong>:\n<ul>\n<li>Oral prednisolone</li>\n<li>IVIG (Intravenous Immunoglobulin)</li>\n</ul>\n</li>\n<li><strong>Second-line</strong> (for persistent/chronic ITP):\n<ul>\n<li>Rituximab</li>\n<li>Thrombopoietin receptor agonists</li>\n<li>Splenectomy (in select chronic cases)</li>\n</ul>\n</li>\n</ul>\n<p>Indications for Platelet Transfusion in ITP:</p>\n<ul>\n<li><strong>Severe mucosal bleeding</strong></li>\n<li><strong>Intracranial hemorrhage</strong></li>\n<li><strong>Before surgery in patients with critically low counts</strong></li>\n</ul>\n<p><strong>Indications for Splenectomy:</strong></p>\n<ul>\n<li>Chronic ITP (&gt;12 months)</li>\n<li>Refractory to medical therapy</li>\n<li>Relapses after tapering off steroids or IVIG</li>\n<li>Age &gt;5 years is preferred for splenectomy due to infection risk in younger children</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Hemarthroses commonly occur in this disorder (Option A):</strong> Hemarthroses are typical of coagulation disorders like <strong>Haemophilia</strong>, not ITP.</p>\n<p><strong>Platelet transfusion should be urgently performed </strong>  <strong>(Option C):</strong> <strong>Platelet transfusions are not routinely indicated</strong> in ITP unless there is life-threatening bleeding.</p>\n<p><strong>Prothrombin time and activated partial thromboplastin time are prolonged (Option D):</strong> Coagulation parameters are <strong>normal</strong> in ITP since it is a platelet destruction disorder, not a coagulation factor deficiency.</p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxyurea</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate-Leucovorin</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Eltrombopag</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Azathioprine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In Sickle Cell Anaemia, which drug is used to decrease the incidence of painful vaso-occlusive crises?</span></p>",
      "unique_key": "DT1230547",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230547,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Hydroxyurea</strong> is the cornerstone drug for reducing <strong>vaso-occlusive crises (VOC)</strong> in patients with sickle cell anaemia.</li>\n</ul>\n<p><strong>Hypothesis / Mechanism of Action:</strong></p>\n<ul>\n<li>Hydroxyurea increases <strong>fetal haemoglobin (HbF)</strong> HbF interferes with haemoglobin S (HbS) polymerisation, which in turn:</li>\n<li>Reduces <strong>sickling</strong> of red cells</li>\n<li>Decreases <strong>vaso-occlusion</strong></li>\n<li>Improves <strong>blood flow</strong> in the microvasculature</li>\n<li>Prevents <strong>acute chest syndrome</strong>, <strong>stroke</strong>, and <strong>painful crises</strong></li>\n</ul>\n<p><strong>Dose</strong>: 10-15 mg/kg/day (once daily); requires regular monitoring of <strong>complete blood counts</strong> for myelosuppression.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250907894f823d-76eb-4687-bf7c-8d4b71e3f111.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Methotrexate-Leucovorin (Option B):</strong> Used in cancers and autoimmune diseases. No role in managing sickle cell crises.</p>\n<p><strong>Eltrombopag (Option C):</strong> A thrombopoietin receptor agonist used for <strong>ITP</strong> and <strong>aplastic anaemia</strong>, not vaso-occlusion.</p>\n<p><strong>Azathioprine (Option D):</strong> An immunosuppressive agent used for autoimmune and transplant cases. Not used in sickle cell disease.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated methylmalonic acid and homocysteine levels</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased serum ferritin</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Target cells on the peripheral smear</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypocellular bone marrow with fatty infiltration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 9-year-old child, born to vegan parents, presents with complaints of fatigue, pallor, and tingling in the feet. On examination, there is glossitis and mild gait disturbance. CBC shows Hb 9.8 g/dL and MCV of 115 fL. Which of the following additional findings would most strongly support the suspected diagnosis?</span></p>",
      "unique_key": "DT1230548",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230548,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong><strong>:</strong></p>\n<ul>\n<li>This child presents with features of <strong>macrocytic anaemia</strong> (MCV &gt;100 fL), <strong>neurological symptoms</strong>, and a <strong>vegan background</strong>, all of which point toward <strong>vitamin B12 deficiency</strong>.</li>\n<li><strong>Vitamin B12 deficiency impairs DNA synthesis</strong>, particularly in rapidly dividing cells like bone marrow precursors, leading to <strong>megaloblastic anaemia</strong>.</li>\n<li><strong>Methylmalonic acid</strong> and <strong>homocysteine</strong> accumulate due to impaired conversion processes dependent on B12, and both are <strong>elevated</strong> in vitamin B12 deficiency.</li>\n<li>These metabolites are <strong>not elevated in folate deficiency</strong>, making them specific diagnostic indicators.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Increased serum ferritin (Option B):</strong> Suggests iron overload or inflammation, not related to macrocytic anaemia.</p>\n<p><strong>Target cells on peripheral smear (Option C):</strong> Typically seen in <strong>thalassemia</strong> or <strong>liver disease</strong>, not B12 deficiency.</p>\n<p><strong>Hypocellular bone marrow with fatty infiltration (Option D):</strong> Seen in <strong>aplastic anaemia</strong>, which presents with pancytopenia, not macrocytosis with neurologic signs.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute chest syndrome</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron overload</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Stroke</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-month-old boy whose parents present to your office for a health supervision visit. The boy is at the third percentile for weight and height. He is pale, and his liver is palpable 3 cm below the costal margin. His parents bring with them laboratory results. If not managed appropriately, this patient's disease course is most likely to be complicated by<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403203b8eb1b2-fc6e-474c-bb52-22eedbf56e38.jpg\"></span></p>",
      "unique_key": "DT1230560",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The clinical and haematological picture is consistent with <strong>beta-thalassemia major</strong>:</p>\n<ul>\n<li><strong>Severe anaemia</strong> (Hb 5.2 g/dL)</li>\n<li><strong>Microcytosis</strong> (MCV 59 fL)</li>\n<li><strong>Haemoglobin electrophoresis</strong> showing <strong>absent HbA</strong>, <strong>markedly elevated HbF (79%)</strong>, and <strong>elevated HbA<sub>2</sub> (21%)</strong></li>\n<li><strong>Hepatomegaly</strong> and <strong>growth retardation</strong> are early clinical signs</li>\n</ul>\n<p>Children with <strong>&beta;-thalassemia major</strong> require <strong>chronic blood transfusions</strong>, which over time lead to <strong>iron overload</strong> due to the absence of a physiological mechanism to excrete excess iron. If not managed with <strong>iron chelation therapy</strong>, complications include:</p>\n<ul>\n<li>Liver damage (fibrosis, cirrhosis)</li>\n<li>Cardiac toxicity (arrhythmias, heart failure)</li>\n<li>Endocrinopathies (hypogonadism, diabetes, hypothyroidism)</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Acute chest syndrome (Option A):</strong> Seen in <strong>sickle cell disease</strong>, not thalassemia.</p>\n<p><strong>Iron deficiency anaemia (Option B):</strong> This patient has iron <strong>overload</strong>, not deficiency, due to repeated transfusions.</p>\n<p><strong>Stroke (Option D):</strong> A complication in <strong>sickle cell disease</strong>, not typical in &beta;-thalassemia major.</p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood transfusion</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Broad-spectrum antibiotics</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Hematopoietic stem cell transplantation</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Immunosuppressive therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 17-year-old girl presents to the clinic with fatigue, pallor, and a recent history of easy bruising. She is afebrile. A complete blood count with differential reveals neutropenia, thrombocytopenia, and elevated mean corpuscular volume, and her reticulocyte count is low. She is referred to a pediatric haematologist, and a diagnosis of severe aplastic anaemia is confirmed, with a haemoglobin of 9.8 g/dL. What is the first-line therapy for this patient's condition?</span></p>",
      "unique_key": "DT1230561",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230561,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Hematopoietic stem cell transplantation (HSCT)</strong> is the <strong>first-line and curative therapy</strong> in children and adolescents with <strong>severe or very severe aplastic anaemia</strong>, <strong>if an HLA-matched sibling donor is available</strong>.</li>\n<li>HSCT provides durable marrow recovery and hematologic cure in &gt;80% of appropriately selected patients.</li>\n<li>This approach is preferred in <strong>younger patients (&lt;20 years)</strong> with an available matched sibling donor, due to the higher success rate and lower long-term complications.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Blood transfusion (Option A):</strong> Supportive but not curative. Repeated transfusions can lead to alloimmunization.</p>\n<p><strong>Broad-spectrum antibiotics (Option B):</strong> Used in febrile neutropenia, but this patient is afebrile. Not a definitive therapy.</p>\n<p><strong>Immunosuppressive therapy (Option D):</strong> This is the first-line option <strong>only when a matched donor is unavailable</strong>, particularly in older children or adults.</p>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Low factor VIII level</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Low factor V level</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor V Leiden</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Low factor VII level</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 1-week-old presents to your office with bruising and coffee ground emesis. She was a term baby who was born at home and is now exclusively breastfed. Her PT is prolonged >100 seconds, and her aPTT is relatively normal. Which of the following is the most likely underlying abnormality?</span></p>",
      "unique_key": "DT1230563",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230563,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>This clinical presentation is consistent with <strong>early-onset Vitamin K deficiency bleeding (VKDB)</strong> in a <strong>breastfed neonate</strong> who did not receive <strong>vitamin K prophylaxis at birth</strong>.</li>\n<li>Vitamin K is essential for &gamma;-carboxylation (activation) of <strong>coagulation factors II, VII, IX, and X</strong>.</li>\n<li><strong>Factor VII</strong>, having the <strong>shortest half-life (~6 hours)</strong>, is the <strong>first to decrease</strong>, leading to <strong>isolated prolonged PT</strong>.</li>\n<li><strong>aPTT may remain normal initially</strong> as factors VIII and IX decline later or are not yet affected.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509075bcf8c2c-43f2-4aa3-9b3b-386e36703064.png\"></li>\n<li>Breastfed neonates are at risk due to <strong>low vitamin K in breast milk</strong>.</li>\n<li>Classical VKDB occurs within the <strong>first 2-7 days</strong>, especially in babies without prophylactic <strong>IM vitamin K</strong>.</li>\n<li><strong>Bleeding manifestations</strong> include GI bleeding, skin bruises, mucosal bleeds, and intracranial haemorrhage in late VKDB.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Low factor VIII level (Option A):</strong> Would prolong <strong>aPTT</strong>, not PT. Seen in Haemophilia<strong> A</strong>, which is not neonatal and does not involve GI bleeding.</p>\n<p><strong>Low factor V level (Option B):</strong> Would prolong <strong>both PT and aPTT</strong> since it is part of the common pathway.</p>\n<p><strong>Factor V Leiden (Option C):</strong> A <strong>thrombophilic</strong> mutation, not associated with bleeding, and especially not in neonates.</p>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Blast crisis in AML</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Sideroblastic anemia</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Fanconi anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old child is brought in with complaints of progressive pallor, fatigue, and intermittent episodes of gum bleeding and low-grade fever over 3 weeks. On examination, there is pallor, petechiae, and mild hepatosplenomegaly. Blood work shows anaemia, thrombocytopenia, and leukocytosis. Peripheral blood smear is shown below. What is the most likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240320966ccca2-c49b-45bc-9f23-37be7b7956b7.jpg\"></span></p>",
      "unique_key": "DT1230565",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230565,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The peripheral smear shows a <strong>blast cell</strong> with a <strong>needle-like inclusion</strong> known as an <strong>Auer rod</strong>, which is <strong>pathognomonic for acute myeloid leukaemia (AML)</strong>.</li>\n<li>Auer rods are fused lysosomes or primary granules, seen <strong>only in myeloid lineage blasts</strong>.</li>\n<li>Clinical presentation of AML in children includes <strong>anaemia, thrombocytopenia, and neutropenia</strong>, with symptoms like fatigue, infections, and bleeding.</li>\n<li>Hepatosplenomegaly and fever are also common.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Blast crisis in AML (Option A) </strong>is seen in <strong>chronic myeloid leukaemia (CML)</strong> progressing to the acute phase. Not used for de novo AML.</p>\n<p><strong>Megaloblastic anaemia (Option B):</strong> Shows <strong>macro-ovalocytes</strong> and <strong>hypersegmented neutrophils</strong>, not blasts or Auer rods.</p>\n<p><strong>Acute lymphoblastic leukaemia (ALL) (Option D):</strong> Lymphoblasts do <strong>not have Auer rods</strong>; diagnosis supported by TdT positivity and absence of cytoplasmic granules.</p>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Sideroblastic anemia</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Anemia of chronic disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child is found to have low serum iron, high ferritin and normal total iron binding capacity. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1230586",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230586,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>This child's iron profile, <strong>low serum iron</strong>, <strong>high ferritin</strong>, and <strong>normal or low TIBC</strong>, is <strong>typical of anaemia of chronic disease (ACD)</strong>.</li>\n<li>In ACD, inflammatory cytokines (especially <strong>IL-6</strong>) increase <strong>hepcidin</strong> production, which inhibits iron release from macrophages and decreases intestinal iron absorption.</li>\n<li>Ferritin, an acute-phase reactant, is <strong>increased</strong>, while TIBC remains <strong>normal or reduced</strong> due to suppressed transferrin production.</li>\n</ul>\n<p><strong>Iron Profile Patterns in Microcytic Anaemias</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240320679bf4c6-47f2-4caa-8f9d-d1672f58051b.jpg\">\n<p><strong>Iron deficiency anaemia (Option A)</strong>: Shows <strong>low serum iron,</strong> <strong>low ferritin</strong>, and <strong>high TIBC</strong>, not consistent here.</p>\n<p><strong>Thalassemia (Option B):</strong> Typically has <strong>normal iron studies</strong> (iron, ferritin, TIBC all normal), and microcytosis disproportionate to anaemia.</p>\n<p><strong>Sideroblastic anaemia (Option C)</strong>: Shows <strong>high serum iron</strong>, <strong>high ferritin</strong>, and <strong>low/normal TIBC</strong>, not low serum iron.</p>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Von Willebrand Disease</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor VIII Deficiency</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor IX Deficiency</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K Deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 13-year-old girl presents with increased bleeding following a dental extraction. Local hemostatic measures were ineffective. Her PT is normal, and she has no prior personal or family history of haemophilia. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1230587",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230587,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The clinical presentation of mucocutaneous bleeding (post-dental extraction), along with <strong>normal PT</strong>, is <strong>highly suggestive of von Willebrand disease (vWD)</strong>, especially <strong>type 1</strong>.</li>\n<li>vWD is the <strong>most common inherited bleeding disorder</strong>, caused by a <strong>quantitative or qualitative defect in von Willebrand factor (vWF)</strong>.</li>\n<li><strong>vWF is essential for platelet adhesion and also stabilises factor VIII</strong>, explaining the associated mild reduction in factor VIII levels in some cases.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509078e86b700-5342-4185-ad0b-20646d9c8138.png\"></li>\n<li>The <strong>Ristocetin cofactor test</strong> is the <strong>gold standard</strong> for assessing vWF function.</li>\n<li>It measures the ability of <strong>vWF to agglutinate platelets in the presence of Ristocetin</strong>.</li>\n<li>It is <strong>reduced in all types of vWD</strong>, especially in <strong>Types 2 and 3</strong>, helping to differentiate from platelet disorders.</li>\n<li><strong>Type 3</strong>vWD behaves similarly to that of <strong>Haemophilia A.</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Factor VIII deficiency (Haemophilia A) (Option B)</strong> and <strong> Factor IX deficiency (Haemophilia B) (Option C)</strong> are both <strong>X-linked recessive</strong>, thus rare in females. They typically cause <strong>deep tissue or joint bleeding</strong>, not mucosal bleeding.</p>\n<p><strong>Vitamin K deficiency (Option D)</strong> causes <strong>prolonged PT and aPTT</strong> due to reduced levels of factors II, VII, IX, X. It's not consistent with isolated post-extraction bleeding in a child with normal PT.</p>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">G-CSF</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Folate</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxyurea</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgens</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 2-year-old boy presents to the emergency department with easy bruising. There is no suspicion of trauma. He has short stature, microcephaly, hyperpigmented skin lesions, bilateral hypoplastic thumbs, and a family history of blood disorders. Laboratory workup reveals pancytopenia. He is diagnosed with a genetic syndrome and planned for HSCT, but no matched donor is available. Which drug is most likely to be started as initial therapy?</span></p>",
      "unique_key": "DT1230594",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230594,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The clinical picture is suggestive of <strong>Fanconi's </strong><strong>Anaemia.</strong></p>\n<ul>\n<li><strong>Fanconi </strong><strong>anaemia</strong>is an acquired <strong>pancytopenia </strong>that includes physical manifestations as well.</li>\n<li>Certain features include <strong>hyperpigmentation or hypopigmentation;</strong>short stature; absent radii; hypoplastic, absent, bifid, or supernumerary thumbs; foot, hip or leg anomalies;<strong> penile or testicular abnormalities (in males)</strong>; uterine, ovarian, or vaginal malformations<strong> (in females);</strong> microcephaly; renal malformations; CVS or GIT malformations.</li>\n<li>Bone marrow failure with <strong>pancytopenia </strong>usually ensues.</li>\n<li><strong>Patients with Fanconi </strong><strong>anaemia</strong>are at <strong>high risk for squamous cell carcinoma</strong> of the head and neck and acute myelogenous leukaemia.</li>\n<li>Management of these patients is<strong>multidisciplinary and should involve a haematologist.</strong></li>\n<li>If an <strong>HLA-matched sibling donor is not available</strong>, the <strong>first-line supportive therapy</strong> is <strong>androgen administration (e.g., oxymetholone or danazol)</strong>.</li>\n<li><strong>Androgens</strong> stimulate erythropoiesis and granulopoiesis and may improve blood counts temporarily in FA patients.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>G-CSF (Option A)</strong> is reserved for <strong>severe neutropenia</strong> with recurrent infections but does not treat pancytopenia.</p>\n<p><strong>Folate (Option B) </strong> is essential in megaloblastic anaemia, but not effective in genetic marrow failure syndromes.</p>\n<p><strong>Hydroxyurea (Option C)</strong> is used in sickle cell anaemia, not in FA.</p>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">G6PD enzyme activity in erythrocytes</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemoglobin electrophoresis</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">UGT1A1 activity</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmotic fragility</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A newborn female develops jaundice at 12 hours of life. Her total serum bilirubin is 22.4 mg/dL, with an indirect (unconjugated) bilirubin level of 21.2 mg/dL. The mother's blood group is AB+, and the baby's blood group is A+. The direct Coombs test is negative.<br> Her CBC shows:<br>WBC: 15,200/mm&sup3;<br>Haemoglobin: 10 g/dL<br>Hematocrit: 30%<br>MCV: 98 fL<br>MCHC: 37 g/dL<br>Platelets: 2.75 lakh/mm&sup3;<br>What is the next best diagnostic test?</span></p>",
      "unique_key": "DT1230597",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230597,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The clinical picture suggests <strong>non-immune hemolytic anaemia</strong>, due to the following clues:</p>\n<ul>\n<li><strong>Early onset jaundice</strong> (&lt;24 hours of life)</li>\n<li><strong>Elevated indirect hyperbilirubinemia</strong> (&gt;20 mg/dL is critical)</li>\n<li><strong>Low haemoglobin (10 g/dL)</strong></li>\n<li><strong>High MCHC (37 g/dL)</strong>- this is a hallmark feature</li>\n<li><strong>Negative Coombs test</strong> rules out Rh/ABO alloimmunization</li>\n</ul>\n<p>These findings are highly suggestive of <strong>hereditary spherocytosis</strong> (HS), a <strong>membrane defect hemolytic anaemia</strong> inherited in an autosomal dominant pattern.</p>\n<p><strong>The osmotic fragility test</strong> is the classical test to <strong>screen for HS</strong>, as spherocytes are fragile in hypotonic solutions.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>G6PD activity (Option A):</strong> More likely in boys (X-linked), and bilirubin rise would not typically be this early unless exposed to oxidative stress.</p>\n<p><strong>Haemoglobin electrophoresis (Option B):</strong> Useful for hemoglobinopathies (e.g., thalassemia, sickle cell), but not acute neonatal jaundice.</p>\n<p><strong>UGT1A1 activity (Option C)</strong>: Relevant in Crigler-Najjar/Gilbert syndrome, which presents later and not with anaemia.</p>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Salmonella typhi</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Parvovirus B19</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptococcus pneumoniae</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Parainfluenza virus 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following microorganisms is the most common cause of aplastic crisis in Sickle Cell Anaemia & Hereditary Spherocytosis?</span></p>",
      "unique_key": "DT1230606",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230606,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Parvovirus B19</strong> infects erythroid precursors in the bone marrow, leading to <strong>transient red cell aplasia</strong>.</li>\n<li>In patients with increased red cell turnover, such as those with <strong>Sickle Cell Disease</strong> or <strong>Hereditary Spherocytosis</strong>, this temporary suppression of erythropoiesis results in a <strong>profound aplastic crisis</strong>.</li>\n<li>Affected children present with <strong>sudden pallor</strong>, <strong>fatigue</strong>, and <strong>marked reticulocytopenia</strong>, often without significant leukopenia or thrombocytopenia.</li>\n<li>The condition is <strong>self-limiting</strong> in most immunocompetent individuals but may require transfusion support during crisis.</li>\n<li><strong>Mnemonic: \"Parvo causes Pause\"</strong> in RBC production.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Salmonella typhi (Option A):</strong> Can cause osteomyelitis in SCD but not aplastic crisis.</p>\n<p><strong>Streptococcus pneumoniae (Option C):</strong> Causes invasive infections in SCD but does not lead to red cell aplasia.</p>\n<p><strong>Parainfluenza virus 1 (Option D):</strong> A respiratory pathogen, not implicated in bone marrow suppression.</p>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Homocysteine deficiency</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Prothrombin gene mutation</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor V deficiency</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephritic syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is associated with an increased risk of thrombosis?</span></p>",
      "unique_key": "DT1230608",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230608,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>prothrombin G20210A mutation</strong> is one of the most common inherited thrombophilias, found in approximately <strong>2-3% of the general population</strong>.</li>\n<li>It leads to <strong>increased prothrombin (factor II) levels</strong>, which increases the risk for <strong>venous thromboembolism</strong> due to enhanced thrombin generation.</li>\n<li><strong>Factor V Leiden</strong> is another common <strong>inherited cause of thrombophilia</strong>, due to a point mutation making factor V <strong>resistant to inactivation by activated protein C (APC resistance)</strong>.</li>\n<li>This increases thrombotic risk significantly.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Homocysteine deficiency (Option A):</strong> Associated with decreased thrombotic risk. <em>Hyperhomocysteinemia</em> increases thrombosis, not deficiency.</p>\n<p><strong>Factor V deficiency (Option C):</strong> Causes <strong>bleeding</strong>, not thrombosis.</p>\n<p><strong>Nephritic syndrome (Option D):</strong> More often associated with hematuria and hypertension than thrombosis.</p>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">2-3 days</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">3-5 days</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">5-7 days</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">10-14 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child suffering from iron deficiency anaemia was started on oral iron therapy. When will the peak reticulocytosis be anticipated after starting iron?</span></p>",
      "unique_key": "DT1230610",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230610,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>In iron deficiency anaemia, once oral iron therapy is initiated, <strong>reticulocytosis</strong> begins within <strong>48-72 hours</strong> and <strong>peaks between days 5-7</strong>.</li>\n<li>This is due to bone marrow erythroid hyperplasia, following the restoration of intracellular iron and improved erythropoiesis.</li>\n</ul>\n<p><strong>Timeline of Response to Iron Therapy</strong></p>\n<ul>\n<li><strong>12-24 hours</strong>: Replacement of intracellular iron enzymes; subjective improvement, such as decreased irritability and increased appetite.</li>\n<li><strong>36-48 hours</strong>: Initial bone marrow response begins; erythroid hyperplasia becomes evident.</li>\n<li><strong>48-72 hours</strong>: Onset of reticulocytosis.</li>\n<li><strong>Peak reticulocytosis: 5-7 days</strong></li>\n<li><strong>4-30 days</strong>: An Increase in haemoglobin concentration is observed.</li>\n<li><strong>1-3 months</strong>: Complete repletion of iron stores occurs.</li>\n</ul>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Painful vasoocclusive crisis</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Splenic sequestration crisis</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute chest syndrome</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Dactylitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Usual indications for an exchange transfusion in a child with sickle cell disease include?</span></p>",
      "unique_key": "DT1230612",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230612,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Acute chest syndrome</strong> is a life-threatening complication of sickle cell disease and is a <strong>primary indication for exchange transfusion</strong>. This therapy rapidly lowers the proportion of sickled haemoglobin (HbS), improves oxygenation, and decreases disease severity.</li>\n</ul>\n<p><strong>Indications for exchange transfusion in sickle cell disease include</strong>:</p>\n<ul>\n<li><strong>Acute chest syndrome</strong></li>\n<li><strong>Stroke (acute CNS event)</strong></li>\n<li><strong>Priapism</strong></li>\n<li><strong>Refractory vaso-occlusive crisis</strong> (not responding to hydration, analgesia, oxygen)</li>\n<li><strong>Multiorgan failure</strong></li>\n<li><strong>High-risk cardiac disease</strong> (e.g., cardiomyopathy)</li>\n<li><strong>Chronic transfusion program</strong> to maintain HbS &lt; 30% after prior stroke</li>\n<li><strong>Acute hepatic sequestration with worsening liver function </strong></li>\n</ul>\n<p><strong>Painful vaso-occlusive crisis</strong> is typically managed with analgesics, hydration, and oxygen; exchange transfusion is considered only in refractory cases. <strong>(Option A is ruled out)</strong></p>\n<p><strong>Splenic sequestration crisis</strong> is usually treated with <strong>simple red cell transfusion</strong>, not exchange. <strong>(Option B is ruled out)</strong></p>\n<p><strong>Dactylitis </strong>is a minor VOC (vaso-occlusive crisis) and usually does not warrant exchange transfusion. <strong>(Option D is ruled out)</strong></p>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">If the patient has >2 episodes of epistaxis in 24 hr</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of hemoglobin of 12 g/dl</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet count of 15000 or less</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">If the patient has Hepatosplenomegaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old was well till 2 days back when he had profuse bleeding from his nose. You suspect him as an ITP initially, but then decide against it. Which of the following will indicate that the diagnosis is NOT ITP and something else?</span></p>",
      "unique_key": "DT1230613",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230613,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>ITP typically presents as an isolated thrombocytopenia</strong> in an otherwise healthy child and may present with mucocutaneous bleeding such as <strong>epistaxis</strong> or <strong>petechiae</strong>.</li>\n<li>However, the presence of <strong>hepatosplenomegaly, generalised lymphadenopathy, or pancytopenia</strong> suggests an alternative diagnosis, such as <strong>leukaemia</strong>, bone marrow infiltration, or other systemic disorders.</li>\n<li>Hence, <strong>hepatosplenomegaly</strong> is a red flag sign against ITP and warrants further evaluation for secondary causes.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>More than two episodes of epistaxis in 24 hours (Option A):</strong> Epistaxis is a common presentation of ITP due to platelet dysfunction. The frequency alone does not rule out ITP.</p>\n<p><strong>Haemoglobin level of 12 g/dL (Option B):</strong> Normal haemoglobin does not contradict the diagnosis of ITP; anaemia may be absent early or in mild cases.</p>\n<p><strong>Platelet count of 15,000/mm&sup3; (Option C):</strong> Severe thrombocytopenia is a classic finding in ITP. Counts below 20,000/mm&sup3; are typical and not a contradiction.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>ITP usually presents with isolated thrombocytopenia and mucocutaneous bleeding.</li>\n<li>The presence of hepatosplenomegaly or lymphadenopathy is atypical and suggests alternate diagnoses.</li>\n<li>A full systemic examination is essential before labelling a case as ITP.</li>\n</ul>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2A</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2B</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2M</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Desmopressin is relatively contraindicated in which type of Von Willebrand disease?</span></p>",
      "unique_key": "DT1230614",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230614,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Type 2B Von Willebrand disease (vWD)</strong> is characterised by <strong>gain-of-function mutations</strong> in the vWF gene that increase the affinity of vWF for platelet glycoprotein Ib (GPIb).</li>\n<li>This enhanced binding causes <strong>spontaneous aggregation of platelets</strong>, leading to their <strong>premature clearance</strong> from circulation.</li>\n<li>Administration of <strong>desmopressin</strong> in these patients can <strong>exacerbate thrombocytopenia</strong> by further increasing circulating levels of vWF that promote platelet-vWF binding.</li>\n</ul>\n<p>Hence, <strong>desmopressin is relatively contraindicated in Type 2B vWD</strong>.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090772e5d92f-a7ac-49c7-b18a-792c31d1b1c5.png\">",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2A</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 3</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudo-vWD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The type of disease having severe thrombocytopenia with decreased vWF and mildly decreased factor 8 levels in blood is:</span></p>",
      "unique_key": "DT1230616",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230616,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Pseudo-von Willebrand disease (pseudo-vWD), also called <strong>platelet-type vWD</strong>, occurs due to a <strong>gain-of-function mutation in platelet glycoprotein Ib (GPIb)</strong>. This mutation increases the spontaneous binding of platelets to circulating vWF, mimicking <strong>Type 2B vWD</strong>.</li>\n<li>The key clinical and laboratory features include:\n<ul>\n<li><strong>Thrombocytopenia</strong></li>\n<li><strong>Decreased vWF activity</strong></li>\n<li><strong>Loss of high-molecular-weight multimers</strong></li>\n<li><strong>Mild decrease in factor VIII levels</strong></li>\n</ul>\n</li>\n<li>Although similar to Type 2B vWD, the <strong>underlying defect is in the platelet receptor</strong>, not the vWF molecule itself. Specific diagnostic tests (e.g., ristocetin-induced platelet aggregation and genetic analysis) are required to distinguish the two conditions.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Type 1 vWD (Option A):</strong> Characterised by partial quantitative deficiency of vWF. Thrombocytopenia is <strong>not typically present</strong>, and factor VIII is usually near normal.</p>\n<p><strong>Type 2A vWD (Option B):</strong> Caused by qualitative defects in vWF, leading to <strong>loss of high-molecular-weight multimers</strong>, but <strong>not associated with significant thrombocytopenia</strong>.</p>\n<p><strong>Type 3 vWD (Option C):</strong> A severe quantitative deficiency of vWF. It causes <strong>very low factor VIII</strong> and <strong>no detectable vWF</strong>, but thrombocytopenia is usually <strong>not a prominent feature</strong>.</p>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Immune thrombocytopenic purpura</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Bernard Soulier Syndrome</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Glanzmann Thrombasthenia</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Parahemophilia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presented with mucosal bleeds, superficial petechiae and purpurae, but no muscle bleeds or joint bleeds. He was evaluated, and his platelet count was found to be normal. His PT and aPTT were also within normal limits. However, the ristocetin assay was abnormal while there was normal platelet aggregation in response to ADP. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1230618",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230618,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>This child has a <strong>platelet function disorder</strong> (normal platelet count + mucocutaneous bleeding).</li>\n<li>PT and aPTT are normal, which <strong>rules out coagulation factor deficiencies</strong>. The key differentiator is the <strong>abnormal response to ristocetin</strong>-this strongly suggests Bernard-Soulier syndrome.</li>\n</ul>\n<p><strong>Ristocetin Test (Mechanism):</strong></p>\n<ul>\n<li>Ristocetin is an antibiotic that promotes <strong>vWF-dependent platelet agglutination</strong> by enabling vWF to bind to <strong>platelet glycoprotein Ib (GpIb)</strong>.</li>\n<li>In <strong>Bernard-Soulier syndrome</strong> (GpIb defect), <strong>abnormal (absent) aggregation with ristocetin</strong>.</li>\n<li>In <strong>vWD (vWF defect)</strong>, also an abnormal response, but corrected with normal plasma.</li>\n<li>In <strong>Glanzmann thrombasthenia (GpIIb/IIIa defect)</strong>: <strong>normal aggregation with ristocetin</strong>, but defective with ADP, collagen, and epinephrine.</li>\n</ul>\n<p><strong>Bernard-Soulier Syndrome vs Glanzmann Thrombasthenia</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250907eca1535b-d91e-4293-987c-cec8ef24fd2b.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Immune thrombocytopenic purpura (ITP) (Option A):</strong> Platelet count would be decreased in ITP. Since this child has a <strong>normal platelet count</strong>, ITP is ruled out.</p>\n<p><strong>Parahemophilia (Option D)</strong> (Factor V deficiency) presents with <strong>abnormal PT and/or aPTT</strong>, not normal coagulation studies. Also, it causes <strong>deep tissue and joint bleeds</strong>, not mucocutaneous bleeding.<br /> </p>",
      "correct_choice_id": 222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor V</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor VIII</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor IX</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor XI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Reduced levels of which clotting factor can produce Haemophilia C?</span></p>",
      "unique_key": "DT1230619",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230619,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Factor XI deficiency</strong>, also known as <strong>Haemophilia C</strong>, is an <strong>autosomal recessive</strong> disorder associated with <strong>mild to moderate bleeding </strong>symptoms<strong>.</strong></li>\n<li>The <strong>bleeding tendency is generally less severe</strong> than that seen in <strong>Haemophilia A (Factor VIII deficiency)</strong> or <strong>Haemophilia B (Factor IX deficiency)</strong>.</li>\n<li>Interestingly, the severity of bleeding <strong>does not correlate with the factor XI level</strong>, unlike other coagulation factor deficiencies.</li>\n<li><strong>Factor XI helps in thrombin generation</strong> and activates the <strong>thrombin-activatable fibrinolysis inhibitor</strong>.</li>\n<li>Therefore, bleeding is often seen in areas of <strong>high fibrinolytic activity</strong>, such as the <strong>oral cavity</strong>, <strong>nasopharynx</strong>, or <strong>urinary tract</strong>.</li>\n<li>Bleeding may occur <strong>after trauma or surgery</strong>, especially dental procedures.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Factor V (Option A):</strong> Deficiency of factor V is called <strong>parahemophilia</strong>, also <strong>autosomal recessive</strong>. It leads to <strong>moderate bleeding</strong>, but it is not termed <strong>Haemophilia C</strong>.</p>\n<p><strong>Factor VIII (Option B):</strong> Deficiency of factor VIII causes <strong>Haemophilia A</strong>, the most common form of haemophilia, inherited as an <strong>X-linked recessive</strong> disorder. It presents with <strong>joint bleeds (hemarthrosis)</strong> and deep tissue bleeding.</p>\n<p><strong>Factor IX (Option C):</strong> Factor IX deficiency causes <strong>Haemophilia B</strong> (Christmas disease), also <strong>X-linked recessive</strong>, and has a similar presentation to Haemophilia A.</p>",
      "correct_choice_id": 234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">It is an X-linked recessive disorder</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">It is caused by a deficiency of clotting factor VIII</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">It presents as a frequent mucosal bleed</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Commonly seen in males</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about Haemophilia A is incorrect?</span></p>",
      "unique_key": "DT1230620",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230620,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Haemophilia A</strong> is a <strong>clotting factor deficiency</strong>, not a platelet disorder, and therefore it does <strong>not</strong> typically present with mucosal bleeds.</li>\n<li>Instead, it manifests as <strong>deep tissue bleeding,</strong> such as <strong>hemarthrosis, muscle bleeds, and intracranial haemorrhage</strong>.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250907f3f2c952-490e-47eb-8135-d1bdc1e9c23b.png\"></li>\n</ul>\n<p><strong>Hemophilia A</strong></p>\n<ul>\n<li>Caused by a deficiency of <strong>Factor VIII</strong>. <strong>(Option B)</strong></li>\n<li>Inherited as an <strong>X-linked recessive</strong> <strong>(Option A)</strong></li>\n<li>Affects <strong>mostly males</strong>; females are typically carriers. <strong>(Option D)</strong></li>\n<li>Presents with <strong>deep tissue bleeds</strong> such as <strong>joint bleeds (hemarthroses)</strong> and <strong>muscle hematomas</strong>.</li>\n</ul>\n<p><strong>Haemophilia B (Christmas Disease)</strong></p>\n<ul>\n<li>Caused by a deficiency of <strong>Factor IX</strong>.</li>\n<li>Inheritance and clinical features are <strong>similar to Haemophilia A</strong>.</li>\n<li>Managed with recombinant <strong>Factor IX</strong></li>\n</ul>\n<p><strong>Hemophilia C</strong></p>\n<ul>\n<li>Caused by a deficiency of <strong>Factor XI</strong>.</li>\n<li>Inherited in an <strong>autosomal recessive</strong> pattern.</li>\n<li>Bleeding is usually <strong>mild</strong>, more prominent after surgery or trauma.</li>\n<li>More common in the <strong>Ashkenazi Jewish</strong> population.</li>\n</ul>",
      "correct_choice_id": 243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Sideroblastic anemia</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-year-old child is suffering from progressive anaemia. On examination, malar prominence and hepatosplenomegaly were seen. Peripheral smear is shown below. What is the likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403208f6cfa6d-27fe-41e2-be87-638a0523a23a.jpg\"></span></p>",
      "unique_key": "DT1230625",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230625,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>The child presents with anaemia, <strong>hepatosplenomegaly</strong>, and <strong>malar prominence</strong>, which are classical signs of a <strong>chronic hemolytic anaemia</strong>.</li>\n<li>The peripheral smear shows <strong>target cells</strong>, which are red blood cells with a central bull's-eye appearance due to excess cell membrane relative to cell volume.</li>\n<li>This morphological change is characteristically seen in <strong>thalassemia</strong> due to defective globin chain synthesis, which alters RBC membrane structure.</li>\n<li>The presence of <strong>target cells</strong> along with clinical features like <strong>progressive anaemia and hemolytic facies</strong> (malar prominence) strongly suggests the diagnosis of <strong>thalassemia</strong>.</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507091de7df77-bc19-48f2-8b14-6301e700561a.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Iron deficiency anaemia (Option A):</strong> Typically presents with microcytic hypochromic anaemia, but <strong>target cells are not prominent</strong>. Peripheral smear usually shows anisopoikilocytosis and pencil cells. Hepatosplenomegaly and malar prominence are not typical.</p>\n<p><strong>Sideroblastic anaemia (Option B):</strong> Usually features <strong>ring sideroblasts</strong> seen on bone marrow Prussian blue stain, not peripheral target cells. It is more commonly associated with mitochondrial defects or secondary causes (e.g., alcohol, drugs).</p>\n<p><strong>Megaloblastic anaemia (Option C):</strong> Characterised by <strong>macrocytic RBCs</strong>, hypersegmented neutrophils, and often due to vitamin B12 or folate deficiency. Target cells are <strong>not</strong> a feature. Clinical features may include glossitis or neuropathy, not hemolytic facies.</p>",
      "correct_choice_id": 254,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">HPLC</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Globin gene sequencing</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferritin</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">BM aspiration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-month-old child with Haemoglobin - 6.3 g/dL was undergoing repeated blood transfusions. A peripheral smear is done, which is shown. The last transfusion was given at 9 months. What is an investigation for definitive diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403204498226f-a0df-43a0-ab87-faa5df3ed482.jpg\"></span></p>",
      "unique_key": "DT1230628",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230628,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>The child has a clinical history of transfusion dependence, and the peripheral smear shows <strong>anisopoikilocytosis with target cells</strong>, suggesting <strong>thalassemia</strong>.</li>\n<li><strong>HPLC and haemoglobin electrophoresis</strong> are initial investigations for thalassemia. However, due to repeated transfusions, results may be inaccurate due to mixed red cell populations.</li>\n<li>Therefore, <strong>globin gene sequencing</strong> is the gold standard to confirm the diagnosis and to determine the specific <strong>thalassemia variant</strong> (&alpha; or &beta; type).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>HPLC (Option A):</strong> Commonly used as a screening tool, but may yield <strong>inconclusive results in recently transfused patients</strong> due to the presence of donor haemoglobin.</p>\n<p><strong>Ferritin (Option C): </strong>Helpful in assessing iron overload, but <strong>not diagnostic</strong> for thalassemia.</p>\n<p><strong>Bone marrow aspiration (Option D): </strong>May show erythroid hyperplasia in thalassemia, but is <strong>invasive</strong> and not required for diagnosis.<br /> </p>",
      "correct_choice_id": 262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune haemolytic anaemia, direct Coombs</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune haemolytic anaemia, indirect Coombs</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary Spherocytosis, osmotic fragility test</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary Elliptocytosis, Coombs test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old child was brought in with episodes of icterus and pallor. What is the probable diagnosis, and what was the investigation done for the same?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240320c7b14419-68af-4397-993c-07212ca2e7b3.jpg\"></span></p>",
      "unique_key": "DT1230629",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230629,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<ul>\n<li>The peripheral smear shows <strong>numerous spherocytes</strong>, small, densely staining RBCs lacking central pallor, which are classic for <strong>Hereditary Spherocytosis (HS)</strong>.</li>\n<li>Children with HS often present with <strong>intermittent jaundice, pallor</strong>, and <strong>splenomegaly</strong> due to extravascular hemolysis.</li>\n<li>The <strong>Osmotic Fragility Test</strong> is the initial diagnostic investigation, which demonstrates increased RBC fragility in hypotonic solutions due to membrane defects.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Autoimmune hemolytic anaemia, direct Coombs (Option A): </strong>Direct Coombs test is positive in autoimmune hemolysis, but AIHA usually shows spherocytes plus <strong>reticulocytosis and hemolysis signs</strong> post-infection or drug exposure, without a consistent chronic pattern.</p>\n<p><strong>Autoimmune hemolytic anaemia, indirect Coombs (Option B):</strong> Indirect Coombs detects circulating antibodies in serum (e.g., in hemolytic disease of the newborn), not useful in HS.</p>\n<p><strong>Hereditary elliptocytosis, Coombs test (Option D)</strong>: Elliptocytosis presents with <strong>elliptical-shaped RBCs</strong>, not spherocytes. Coombs' test is not relevant here.</p>",
      "correct_choice_id": 273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Myelodysplasia</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Aplastic anemia</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">ITP</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">PNH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old with a history of recurrent infection and bleeding gums. On investigations, the patient had pancytopenia, and the peripheral smear showed macrocytes. Bone marrow biopsy showed no megakaryocytes and was filled with fat globules. What is your diagnosis?</span></p>",
      "unique_key": "DT1230631",
      "question_audio": null,
      "question_video": null,
      "map_id": 1230631,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Aplastic anaemia</strong> is characterised by <strong>peripheral pancytopenia</strong> (low counts of all blood cells) along with a <strong>hypocellular or fatty bone marrow</strong>. In this patient:</p>\n<ul>\n<li>History of <strong>recurrent infections and gum bleeding</strong>- suggest neutropenia and thrombocytopenia.</li>\n<li><strong>Pancytopenia on smear</strong> and <strong>macrocytes</strong> are common in aplastic anaemia.</li>\n<li><strong>Fatty marrow with absent megakaryocytes</strong> confirms aplastic anaemia.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Myelodysplasia (Option A):</strong> Also causes pancytopenia but is typically associated with <strong>dysplastic changes</strong> in cells and a <strong>hypercellular marrow</strong>, not fatty infiltration. More common in adults.</p>\n<p><strong>ITP (Option C):</strong> Characterised by <strong>isolated thrombocytopenia</strong>. Bone marrow is otherwise normal or may show <strong>increased megakaryocytes</strong>. Pancytopenia rules it out.</p>\n<p><strong>PNH (Option D):</strong> Paroxysmal nocturnal hemoglobinuria can present with pancytopenia, but the bone marrow is <strong>normocellular or hypercellular</strong>, not fatty. Also presents with <strong>hemolysis</strong> and <strong>thrombosis</strong>, not seen here.</p>",
      "correct_choice_id": 282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}